Author

Stephanie Kreis

University of LuxembourgORCID 0000-0003-1865-3889Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Andrei Y. ZinovyeviD· 1 shared Anke K. Wienecke-BaldacchinoiD· 1 shared Arnaud MulleriD· 1 shared Catherine RolveringiD· 1 shared Claude HaaniD· 1 shared Dorothée Nashan· 1 shared Francisco J AzuajeiD· 1 shared Gunnar A. G. DittmariD· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Andrei Y. ZinovyevORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 23, 2024

Metabolism-oriented compound screen in physiological culture conditions identifies a NAMPT inhibitor highly effective against drug-naive and -resistant melanoma cells

Jasmin Renate Preis, Catherine Rolvering, Mélanie Kirchmeyer…·Claude Haan

The paper identifies FK866, a NAMPT inhibitor, as effective against drug-naive and -resistant melanoma cells in various culture conditions without affecting healthy cells.

2 citations

humanproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintAug 20, 2018

Independent component analysis provides clinically relevant insights into the biology of melanoma patients

Petr V. Nazarov, Anke K. Wienecke-Baldacchino, Andrei Y. Zinovyev…·Stephanie Kreis

The paper uses independent component analysis to analyze melanoma transcriptomic data, distinguishing biological signals from technical biases and identifying clinically relevant patient characteristics.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky